Table 2 Metabolites potentially derived from the microbiota identified in the comparison between ovarian Cancer (OC) and Gastrointestinal Cancer (GI) groups
Potential Microbiota-derived metabolites (GI vs. OC) | Phylum | ||
|---|---|---|---|
Bacteria | Eukaryota/Fungi | Archaea | |
Thymol | / | Ascomycota | / |
Benzamide | Proteobacteria, Verrucomicrobia, Synergistetes, Firmicutes, Actinobacteria, Bacteroidetes, Spirochaetes, Fusobacteria, Planctomycetes | / | Thaumarchaeota, Euryarchaeota, |
LPC 20:1 | Bacteroidetes, Firmicutes | / | / |
Caffeine | Bacteroidetes, Firmicutes, Proteobacteria | / | / |
Glucosamine | Actinobacteria, Bacteroidetes, Firmicutes, Proteobacteria, Verrucomicrobia, Spirochaetes, Fusobacteria, Synergistetes, Tenericutes, Planctomycetes | Ascomycota, Euglenozoa, | Euryarchaeota |
LPC 20:2 | Bacteroidetes, Firmicutes | / | / |
Levulinic acid | Firmicutes | / | / |
D-Tagatose | Firmicutes, Proteobacteria, Thermotogae, Actinobacteria | / | / |
LPC 22:4 | Bacteroidetes, Firmicutes | / | / |
3-Methylxanthine | Bacteroidetes, Firmicutes, Proteobacteria | / | / |
D-Glucurono-6,3-lactone | Proteobacteria | / | / |
Phosphocholine | Bacteroidetes, Firmicutes, Proteobacteria, Actinobacteria, Fusobacteria | Ascomycota | Thaumarchaeota, Euryarchaeota, Crenarchaeota |
Trimethylamine N-oxide | Firmicutes, Proteobacteria, Actinobacteria, Verrucomicrobia, Bacteroidetes | / | Euryarchaeota |
3-Methylindole | Firmicutes | / | / |
LPC 22:1 | Bacteroidetes, Firmicutes | / | / |
LPC 18:1 | Bacteroidetes, Firmicutes | / | / |
Sphinganine | Firmicutes | Ascomycota, Basidiomycota | Euryarchaeota |